Market Tracker

10/31 1:10pm ET

Immunomedics Inc (NASDAQ:IMMU)

3.99
Data as of 12:55pm ET
 -0.01 / -0.25%
Today’s Change
3.04
Today|||52-Week Range
6.17
-13.26%
Year-to-Date

Today’s Trading

Previous close4.00
Today’s open4.11
Day’s range3.95 - 4.15
Volume339,810
Average volume (3 months)650,302
Market cap$369.7M
Dividend yield--
Data as of 12:55pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-8.73%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book9.39

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+1.05+5.30%
LMNSLumenis Ltd+0.22+2.45%
CLDNCelladon Corp+0.34+3.16%
IVCInvacare Corp+0.04+0.25%
Data as of 1:09pm ET, 10/31/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts